Novo CEO pressed by Senate to cut charges of obesity, diabetes medicines CEO Lars Fruergaard Jørgensen informed lawmakers the organization would contemplate new talks with insurers about the listing rates of Wegovy and copyright if they pledge to keep the medicines on their own formularies. Financial commitment in digital overall https://busch-light-peach-nutriti74185.tblogz.com/considerations-to-know-about-healthcare-news-44665165